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Introduction: The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability
(FINGER) successfully demonstrated that multidomain lifestyle intervention can improve or maintain
cognitive functioning in at-risk individuals. Health-related quality of life (HRQoL) was a secondary
endpoint.
Methods: The intervention (n = 631) aimed at healthy diet, increased physical activity, cognitive training,
and vascular risk management. The control group (n = 629) was given general health advice. HRQoL was
assessed at baseline, 12, and 24 months using validated RAND-36 (SF-36) instrument with 8 scales.
Results: During the 2-year intervention period, mean scores in all scales decreased in the control group,
but increased in the intervention group for vitality (12 months), social function (12 months), and
especially general health at both 12 and 24 months. There was a statistically signiﬁcant beneﬁcial effect
of intervention on the change in general health and physical function at 12 and 24 months.
Conclusion: Multidomain lifestyle intervention improved also important dimensions of HRQoL.
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The Finnish Geriatric Intervention Study to Prevent Cognitive
Impairment and Disability (FINGER) is a ‘‘proof-of-concept’’
double-blind, randomized controlled trial, which successfully
demonstrated that a 2-year multidomain lifestyle intervention
— consisting of exercise, dietary counselling, cognitive training,
and cardiovascular risk factor control — can improve or maintain
cognitive functioning in older persons at risk of cognitive decline
[1]. A further beneﬁcial dimension of the intervention would be its
potential effect on health-related quality of life (HRQoL), a
clinically important endpoint in outcome research in older people
[2]. An improvement in HRQoL could provide added value, and
analysis of HRQoL might also help to discern efﬁcient parts of the
multidomain intervention. We report here the in-trial changes of
HRQoL in the intervention and control groups.y. All rights reserved.
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The FINGER study is registered at Clinicaltrials.gov
(NCT01041989). FINGER participants were recruited from earlier
population-based surveys in Finland, and inclusion criteria were
Cardiovascular Risk Factors, Aging and Dementia (CAIDE) Demen-
tia Risk Score at least 6 points and their cognition average or
slightly lower than expected for age. Between Sept 7, 2009, and
Nov 24, 2011, 2654 individuals were screened and 1260 commu-
nity-dwelling individuals aged 60 to 77 years were randomly
assigned to intervention (n = 631) and control (n = 629) groups
[1]. The two-year intervention aimed at healthy diet, increased
physical activity, cognitive training, and evidence-based vascular
risk management and monitoring. The control group was given
general health advice.
Study participants were not actively told of their group
allocation, and the assessors of study outcomes were blinded to
group allocation. Analysis was by modiﬁed intention to treat (all
participants with at least one post-baseline observation). The
primary outcome was cognitive performance, change in cognition
measured with comprehensive neuropsychological test battery
(NTB) Z score, and the results showed a statistically signiﬁcant
between-group difference in the change of NTB total score per year
(0.022, 95% CI: 0.002–0.042, P = 0.030 [1]). NTB was selected
because a sensitive cognitive test was required in this population
with MMSE  26 points at baseline.
HRQoL was a pre-speciﬁed secondary outcome, and it was
measured using the RAND-36 (Medical Outcomes Study 36-Item
Short-Form Health Survey; practically identical to Short Form [SF]-
36) with its 8 scales: Physical Function (PF), Role Physical (RP), Role
mental (RM), Vitality (VT), Mental Health (MH), Social Function
(SF), Bodily Pain (BP), and General Health (GH) [3]. HRQoL
assessments were performed at baseline, 12, and 24 months.
The results of RAND-36 have been validated in the Finnish
population, and population standards for the 8 scales are available
[4].
3. Statistical analysis
Mplus (Version 5) was used for ﬁtting Growth mixture models
(GMM) with robust maximum likelihood estimation method. Logit
link was used to analyze the relationships between categorizedTable 1
Baseline Characteristics of FINGER Participants.
Demographic characteristics Intervention
Age at baseline visit, mean (SD) 69.5 (4.6) 
Proportion of women, % 45 
Education, years, mean (SD) 10.0 (3.4) 
MMSE, points, mean (SD) 26.7 (2.0) 
RAND-36 scalesa,
age and sex-adjusted
No. of participants with
measurement
Interve
Physical function 1253 79.0 (0
Role physical 1238 73.1 (1
Role mental 1232 80.5 (1
Vitality 1242 71.0 (0
Mental health 1244 81.8 (0
Social function 1248 87.8 (0
Bodily pain 1249 74.4 (0
General health 1251 58.4 (0
SD: standard deviation.
a The scores of the RAND-36 scales can range from 0 (worst) to 100 (best).
b From reference [4].
c Mean (SE).
d Signiﬁcantly different from control.scales (RP, RM, SF) and latent growth factors. GMMs are more
complex than mixed models used in the cognition report of FINGER
[1], since they are based on mixtures of distributions to handle
large discrepancies from normal distribution. Estimation of
separate mixture distributions is based on latent class analysis
in which, as a ﬁrst step, models with different number of latent
classes are estimated (here models with 1–5 latent classes) and the
best ﬁtting model was chosen. In-depth information on statistical
details can be found in Mplus references [5,6].
Effect size was calculated using Cohen’s d formula, i.e.
difference score of intervention and control group changes
compared to baseline score divided by baseline standard deviation.
These values were given separately for 12-month and 24-month
effects because non-linear model for change was adopted.
A 2-sided P-value of < 0.05 was considered statistically
signiﬁcant.
4. Results
At baseline, the scores in all RAND-36 scales were considerably
higher in FINGER participants compared with the Finnish
population of similar age (Table 1). During the 2-year intervention
period, mean scores in all scales decreased in the control group, but
increased in the intervention group for VT (12 months), SF
(12 months), and especially GH at both 12 and 24 months. There
was a statistically signiﬁcant beneﬁcial effect of intervention on
the change in GH and PF at 12 and 24 months (Table 2). Effect sizes
for most RAND-36 scales were small (0.02–0.08), however higher
for GH (0.18–0.20; Table 2).
5. Discussion
In an older population at-risk of dementia, a multidomain
intervention to improve or maintain cognitive functioning also had
a beneﬁcial effect on several scales of a validated HRQoL
instrument, RAND-36 [3], although the effect sizes were not large.
However, the net differences in GH scores were greater, between
groups they were > 3 points. This is considered clinically
meaningful in RAND-36 [3] — and this difference persisted for
2 years. The effect size of GH difference was 0.18–0.20, which is
greater than that of cognitive difference (0.13), primary endpoint









people aged 65 and overb
.8)c 80.1 (0.8) 60.6
.4) 75.7 (1.4) 47.0
.3) 80.8 (1.3) 58.8
.8) 71.6 (0.8) 60.7
.6) 81.1 (0.6) 74.8
.7) 88.9 (0.7) 77.3
.9) 74.1 (0.9) 64.2
.7)d 61.9 (0.7) 49.0
Table 2
Effect of intervention on the change in RAND-36 scales from baseline to 12 and 24 months.
RAND-36 scales Estimated mean change (intervention/control) in domains during intervention perioda






















Physical function 1253 1.2 (0.003) 2.5 (< 0.001) 0.045 0.06 2.3 (< 0.001) 4.0 (< 0.001) 0.013 0.08
Role physical 1238 1.6 (0.27) 4.5 (0.014) 0.29 0.08 1.7 (0.43) 4.7 (0.004) 0.11 0.08
Role mental 1232 0.1 (0.95) 0.9 (0.51) 0.57 0.02 0.1 (0.95 1.7 (0.29) 0.41 0.05
Vitality 1242 0.7 (0.20) 0.7 (0.34) 0.11 0.07 0.3 (0.64) 0.9 (0.026) 0.49 0.03
Mental health 1244 0.3 (0.40) 0.3 (0.48) 0.97 0.0 0.6 (0.17) 0.9 (0.061) 0.56 0.02
Social function 1248 0.5 (0.38) 0.5 (0.39) 0.21 0.06 0.8 (0.057) 1.2 (0.043 0.53 0.02
Bodily pain 1249 1.3 (0.07) 1.1 (0.52) 0.87 0.01 2.4 (0.086 2.1 (0.099) 0.89 0.01
General health 1251 1.6 (0.026) 1.8 (0.004) < 0.001 0.20 1.5 (0.003) 1.6 (0.050) < 0.001 0.18
a Mean values are estimated based on the growth mixture models adjusted for age, sex, education years, and points of Mini Mental State Examination (MMSE) at baseline.
b Effect size was calculated as described in Methods.
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control group, even though FINGER participants had a relatively
good HRQoL at baseline as compared to population standards
[4]. Even though the FINGER participants were population-driven,
common experience is that voluntary participants in trials may
differ in various ways from non-participants [7].
The results on GH are especially interesting, because self-rated
health (‘‘self-perceived health’’ [SRH]), one component of the GH
scale in RAND-36, has been repeatedly shown to be associated with
important clinical outcomes including mortality, disability, and
use of social insurance facilities and health care services [8–13],
independently of conventional risk factors. Recently, SRH has also
been shown to predict the development of old age frailty during
long-term in clinically healthy middle-aged men [14]. SRH is
considered to represent a global perception of an individual’s
current state of health, which is not necessarily identical with
objective state of health.
Conseptualizing SRH is challenging, both biology and culture
are involved [15], but among the SF-36/RAND-36 scales it is more
strongly related to physical functioning than dimensions of mental
health and social functioning [16]. Nevertheless, improvement in
GH and SRH may also represent better stress-handling ability and
coping [10]. The effects of the FINGER intervention on HRQoL
therefore complement the beneﬁcial effects of the intervention on
the primary outcome, cognition, and present a potential of the
multidomain intervention to improve overall health and well-
being of older individuals.
The present results may also hint how various parts of the
multidomain intervention contributed to the clinical results of the
trial. Physical exercise is interesting here because PF was improved
in the intervention group, and physical function is also an
important determinant of SRH [16]. However, a recent systematic
review could not establish evidence that aerobic physical exercise
alone would have cognitive beneﬁt in cognitively healthy older
people [17]. On the other hand, in the randomized Finnish
Alzheimer disease exercise trial (FINALEX) physical exercise alone
improved physical function [18], but had limited effect on
cognition (only executive function) in established memory disease
[19]. FINGER participants differed from those studies, because their
cognition was average or slightly below average and they received
multidomain intervention. Forthcoming analyses of adherence
during FINGER intervention period will give more data on the issue
of how various components of the multidomain intervention were
associated with changes in cognition.
Strengths of the present study include the randomized,
controlled design, low drop-out rate, and use of generic and
validated HRQoL instrument. Limitations include the small effect
sizes between groups and potential presence of the regression tothe mean phenomenon. Also, it is impossible to conclusively mask
the study group membership in this type of study and this may
affect self-reported data, such as HRQoL. Finally, long-term effects
and sustainability of the beneﬁcial effects are not known.
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